Nvision Biomedical Technologies Expands Lower Extremities Product Portfolio with FDA-cleared Osteotomy Wedge System
SAN ANTONIO (PRWEB) FEBRUARY 19, 2020
Nvision Biomedical Technologies, a San Antonio-based medical device and implant manufacturer, will highlight its growing product portfolio for lower extremities at the American College of Foot and Ankle Surgeons Annual Scientific Conference, February 18-22 at the Henry B. Gonzalez Convention Center. The Trigon® Ti Stand-Alone Osteotomy Wedge Fixation System will lead Nvision’s innovative showcase. The Trigon titanium wedge system, which was cleared by the FDA in December, is the most advanced 3D-manufactured titanium stand-alone osteotomy wedge system for both Evans and Cotton surgical procedures.
“Flat Foot correction is one of the most common surgeries for lower extremities, and like our other innovations, we identified opportunities to improve patient outcomes,” said Tom Zink, Nvision Senior Vice President of Product Development. “The Trigon wedge enables a standard surgical technique that allows direct and exact placement of implant and screws without the need for additional plating.”
Nvision has observed patient success with its spinal interbody fusion product lines using 3D-printed medical grade titanium alloy (Ti-6AI-4V) interbody cages. The Trigon titanium wedge utilizes additive manufacturing and 3D-printed medical-grade titanium alloy (Ti-6AI-4V) material featuring an anatomic design with a three–dimensional scaffold imitating cancellous bone which allows for blood and bone integration, along with a graft window for the placement of biologic material if desired.
After initially focusing on spinal implants, Nvision is now applying many of the same advanced technologies to lower extremity surgery. The company launched the Vector® Hammertoe Correction System into the market in March 2019. An industry first, the hammertoe system is the only foot and ankle implant made from the advanced, biocompatible PEEK-OPTIMA™ HA Enhanced, a polymer from Invibio Biomaterial Solutions™. It is also the first lower extremity (Proximal Interphalangeal Joint Arthrodesis) implant to use Structural Encoding®, a patented technology platform licensed from Watershed Idea Foundry, that enables the Unique Device Identification (UDI) required by the FDA.
With a focus on continuing to drive innovation for the foot and ankle segment, Nvision has several new products in the pipeline, including an addition to the Trigon wedge system developed with PEEK-OPTIMA HA Enhanced that has been submitted for FDA clearance. With the addition of the Trigon PEEK HA Enhanced line, Nvision remains at the forefront in taking this advanced material into foot and ankle surgeries.
About Nvision Biomedical Technologies
Nvision is a San Antonio-based medical device and implant manufacturer focused on providing surgeons with implants paired with instrumentation and biologics that simplify and improve surgery procedures to help patients get back to their quality of life. Nvision is committed to developing and manufacturing thoughtfully designed products combined with exceptional service that keep the patient, surgeons, healthcare providers, and distribution partners in mind. Nvision is aligned with surgeon thought leaders, key researchers, and development engineers from prestigious institutions to design, test, and bring to market the most innovative concepts.
